1. The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity

   • Alberto Verrotti
   • Romina Moavero
   • Paolo Curatolo

   Review Article 25 October 2017 Pages: 1 - 8

2. A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe

   • Josiah T. Masuka
   • Precious Chipangura
   • Star Khoza

   Original Research Article 30 September 2017 Pages: 9 - 17

   

3. Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus

   • Noboru Kurinami
   • Seigo Sugiyama
   • Hideaki Jinnouchi

   Original Research Article Open access 02 November 2017 Pages: 19 - 27

   

4. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study

   • Akiko Mizukami
   • Keiko Sato
   • Desmond Curran

   Original Research Article Open access 30 October 2017 Pages: 29 - 37

   

5. Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction

   • Mikie Yamato
   • Kyoichi Wada
   • Mitsutaka Takada

   Original Research Article 27 October 2017 Pages: 39 - 48

   

6. Improvements in Quality-Adjusted Life Years and Cost–Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study

   • Eiichiro Kamagata
   • Kazuo Yamada

   Original Research Article 14 October 2017 Pages: 49 - 55

   

7. Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects

   • Maulik R. Patel
   • Kevinkumar A. Kansagra
   • Nuggehally R. Srinivas

   Original Research Article 11 October 2017 Pages: 57 - 65

   

8. Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece

   • Charalampos Tzanetakos
   • Alexandra Bargiota
   • Nikos Maniadakis

   Original Research Article 27 October 2017 Pages: 67 - 77

   

9. Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China

   • Na Li
   • Bin Zheng
   • Mao-Bai Liu

   Original Research Article 13 October 2017 Pages: 79 - 86